Literature DB >> 18209513

Buprenorphine: new tricks with an old molecule for pain management.

Howard A Heit1, Douglas L Gourlay.   

Abstract

Sublingual buphrenorphine is a unique opioid medication based on its pharmacokinetics and pharmacodynamic properties. It may be used "on label" as an alternative choice to methadone for the treatment of opioid addiction or "off-label" for the treatment of both acute and chronic pain. Because of high mu receptor affinity and resultant blockade, it has been suggested that this might interfere with the management of moderate to severe pain in patients on opioid agonist treatment. The following article will offer strategies and approaches to address some of these real and perceived challenges.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18209513     DOI： 10.1097/AJP.0b013e31815ca2b4

Source DB:  PubMed          Journal:  Clin J Pain        ISSN： 0749-8047            Impact factor:   3.442


  15 in total

1.  Comparison of a drug versus money and drug versus drug self-administration choice procedure with oxycodone and morphine in opioid addicts.

Authors:  Sandra D Comer; Verena E Metz; Ziva D Cooper; William J Kowalczyk; Jermaine D Jones; Maria A Sullivan; Jeanne M Manubay; Suzanne K Vosburg; Mary E Smith; Deena Peyser; Phillip A Saccone
Journal:  Behav Pharmacol       Date:  2013-09       Impact factor: 2.293

2.  Treating Chronic Pain: Is Buprenorphine the (or Even an) Answer?

Authors:  Eric C Sun; Jianren Mao; T Anthony Anderson
Journal:  Anesth Analg       Date:  2018-08       Impact factor: 5.108

3.  The subjective, reinforcing, and analgesic effects of oxycodone in patients with chronic, non-malignant pain who are maintained on sublingual buprenorphine/naloxone.

Authors:  Jermaine D Jones; Maria A Sullivan; Jeanne Manubay; Suzanne K Vosburg; Sandra D Comer
Journal:  Neuropsychopharmacology       Date:  2010-10-27       Impact factor: 7.853

Review 4.  Treating Chronic Pain: An Overview of Clinical Studies Centered on the Buprenorphine Option.

Authors:  Mellar P Davis; Gavril Pasternak; Bertrand Behm
Journal:  Drugs       Date:  2018-08       Impact factor: 9.546

Review 5.  Prescription opioid abuse, pain and addiction: clinical issues and implications.

Authors:  Walter Ling; Larissa Mooney; Maureen Hillhouse
Journal:  Drug Alcohol Rev       Date:  2011-05

Review 6.  To Stop or Not, That Is the Question: Acute Pain Management for the Patient on Chronic Buprenorphine.

Authors:  T Anthony Anderson; Aurora N A Quaye; E Nalan Ward; Timothy E Wilens; Paul E Hilliard; Chad M Brummett
Journal:  Anesthesiology       Date:  2017-06       Impact factor: 7.892

7.  Activity of new NOP receptor ligands in a rat peripheral mononeuropathy model: potentiation of morphine anti-allodynic activity by NOP receptor antagonists.

Authors:  Taline V Khroyan; Willma E Polgar; Juan Orduna; Faming Jiang; Cris Olsen; Lawrence Toll; Nurulain T Zaveri
Journal:  Eur J Pharmacol       Date:  2009-03-12       Impact factor: 4.432

Review 8.  Opioids and the treatment of chronic pain: controversies, current status, and future directions.

Authors:  Andrew Rosenblum; Lisa A Marsch; Herman Joseph; Russell K Portenoy
Journal:  Exp Clin Psychopharmacol       Date:  2008-10       Impact factor: 3.157

9.  Sublingual buprenorphine/naloxone for chronic pain in at-risk patients: development and pilot test of a clinical protocol.

Authors:  Andrew Rosenblum; Ricardo A Cruciani; Eric C Strain; Charles M Cleland; Herman Joseph; Stephen Magura; Lisa A Marsch; Laura F McNicholas; Seddon R Savage; Arun Sundaram; Russell K Portenoy
Journal:  J Opioid Manag       Date:  2012 Nov-Dec

10.  Sublingual buprenorphine for chronic pain: a survey of clinician prescribing practices.

Authors:  Kristen Rosen; Antonio Gutierrez; Deborah Haller; Jennifer S Potter
Journal:  Clin J Pain       Date:  2014-04       Impact factor: 3.442
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.